HighTower Advisors
WVE icon

HighTower Advisors’s Wave Life Sciences WVE Stock Holding History

HighTower Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
29,232
+6,402
+28% +$83.4K ﹤0.01% 3440
2025
Q4 		$388K Buy
22,830
+10,666
+88% +$108K ﹤0.01% 2828
2025
Q3 		$89K Buy
+12,164
New +$98.4K ﹤0.01% 3557

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HighTower Advisors's WVE Position: Q1 2026 in Review

HighTower Advisors increased its Wave Life Sciences (WVE) stake by 28% in Q1 2026, buying an estimated $83.4K and bringing the position to 29,232 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3440.

HighTower Advisors first reported a position in WVE in Q3 2025 and has held it in 3 quarters since. The position peaked at $388K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • HighTower Advisors held 29,232 shares of Wave Life Sciences worth $212K as of Q1 2026.
  • HighTower Advisors bought 6,402 Wave Life Sciences shares in Q1 2026, an estimated $83.4K.
  • Wave Life Sciences made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3440 holding.
  • HighTower Advisors first reported a position in Wave Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • HighTower Advisors's Wave Life Sciences position peaked at $388K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.